Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Obesity

  Free Subscription


Articles published in N Engl J Med

Retrieve available abstracts of 34 articles:
HTML format



Single Articles


    September 2022
  1. KUHNEN P, Clement K
    Long-Term MC4R Agonist Treatment in POMC-Deficient Patients.
    N Engl J Med. 2022;387:852-854.
    PubMed    


    August 2022
  2. BRAMANTE CT, Huling JD, Tignanelli CJ, Buse JB, et al
    Randomized Trial of Metformin, Ivermectin, and Fluvoxamine for Covid-19.
    N Engl J Med. 2022;387:599-610.
    PubMed     Abstract available


    July 2022
  3. DE OLIVEIRA EM, Keogh JM, Farooqi IS
    Obesity-Associated GNAS Mutations and the Melanocortin Pathway. Reply.
    N Engl J Med. 2022;387:285-286.
    PubMed    


  4. KLEINENDORST L, Boon E, van Haelst MM
    Obesity-Associated GNAS Mutations and the Melanocortin Pathway.
    N Engl J Med. 2022;387:285.
    PubMed    


  5. OKUBO J, Mancini MC, de Melo ME
    Obesity-Associated GNAS Mutations and the Melanocortin Pathway.
    N Engl J Med. 2022;387:284.
    PubMed    


  6. POON KS, Tan KM
    Obesity-Associated GNAS Mutations and the Melanocortin Pathway.
    N Engl J Med. 2022;387:284.
    PubMed    


  7. CREANGA AA, Catalano PM, Bateman BT
    Obesity in Pregnancy.
    N Engl J Med. 2022;387:248-259.
    PubMed    


    June 2022
  8. JASTREBOFF AM, Aronne LJ, Ahmad NN, Wharton S, et al
    Tirzepatide Once Weekly for the Treatment of Obesity.
    N Engl J Med. 2022 Jun 4. doi: 10.1056/NEJMoa2206038.
    PubMed     Abstract available


  9. ROSEN CJ, Ingelfinger JR
    Shifting Tides Offer New Hope For Obesity.
    N Engl J Med. 2022 Jun 4. doi: 10.1056/NEJMe2206939.
    PubMed    


    April 2022
  10. LIU D, Huang Y, Huang C, Yang S, et al
    Calorie Restriction with or without Time-Restricted Eating in Weight Loss.
    N Engl J Med. 2022;386:1495-1504.
    PubMed     Abstract available


    February 2022
  11. CYPESS AM
    Reassessing Human Adipose Tissue.
    N Engl J Med. 2022;386:768-779.
    PubMed    


    December 2021
  12. HAGAN S
    E66.01 and Our Culture of Shame.
    N Engl J Med. 2021;385:2307-2309.
    PubMed    


    October 2021
  13. JUPPNER H
    Obesity and Galphas Variants.
    N Engl J Med. 2021 Oct 6. doi: 10.1056/NEJMe2113123.
    PubMed    


  14. MENDES DE OLIVEIRA E, Keogh JM, Talbot F, Henning E, et al
    Obesity-Associated GNAS Mutations and the Melanocortin Pathway.
    N Engl J Med. 2021 Oct 6. doi: 10.1056/NEJMoa2103329.
    PubMed     Abstract available


    August 2021
  15. JENSEN SBK, Torekov SS
    Healthy Weight Loss Maintenance with Exercise, Liraglutide, or Both Combined. Reply.
    N Engl J Med. 2021;385:573-574.
    PubMed    


  16. OKECHUKWU CE
    Healthy Weight Loss Maintenance with Exercise, Liraglutide, or Both Combined.
    N Engl J Med. 2021;385:572-573.
    PubMed    


  17. DE SOUTO BARRETO P, Rolland Y
    Healthy Weight Loss Maintenance with Exercise, Liraglutide, or Both Combined.
    N Engl J Med. 2021;385:572.
    PubMed    


    July 2021
  18. ROSEN CJ, Ingelfinger JR
    Once-Weekly Semaglutide in Adults with Overweight or Obesity. Reply.
    N Engl J Med. 2021;385:e4.
    PubMed    


  19. WILDING JPH, Calanna S, Kushner RF
    Once-Weekly Semaglutide in Adults with Overweight or Obesity. Reply.
    N Engl J Med. 2021;385:e4.
    PubMed    


  20. SRIVASTAVA G, Kumar RB
    Once-Weekly Semaglutide in Adults with Overweight or Obesity.
    N Engl J Med. 2021;385:e4.
    PubMed    


  21. NADOLSKY KZ, Agarwal M
    Once-Weekly Semaglutide in Adults with Overweight or Obesity.
    N Engl J Med. 2021;385:e4.
    PubMed    


  22. KHOO TK, Lin J
    Once-Weekly Semaglutide in Adults with Overweight or Obesity.
    N Engl J Med. 2021;385:e4.
    PubMed    


  23. JAVOR E, Lucijanic M, Skelin M
    Once-Weekly Semaglutide in Adults with Overweight or Obesity.
    N Engl J Med. 2021;385:e4.
    PubMed    


    June 2021
  24. WU JM
    Stress Incontinence in Women.
    N Engl J Med. 2021;384:2428-2436.
    PubMed    


    May 2021
  25. LUNDGREN JR, Janus C, Jensen SBK, Juhl CR, et al
    Healthy Weight Loss Maintenance with Exercise, Liraglutide, or Both Combined.
    N Engl J Med. 2021;384:1719-1730.
    PubMed     Abstract available


    March 2021
  26. RATHMELL JC
    Obesity, Immunity, and Cancer.
    N Engl J Med. 2021;384:1160-1162.
    PubMed    


  27. INGELFINGER JR, Rosen CJ
    STEP 1 for Effective Weight Control - Another First Step?
    N Engl J Med. 2021;384:1066-1067.
    PubMed    


    February 2021
  28. WILDING JPH, Batterham RL, Calanna S, Davies M, et al
    Once-Weekly Semaglutide in Adults with Overweight or Obesity.
    N Engl J Med. 2021 Feb 10. doi: 10.1056/NEJMoa2032183.
    PubMed     Abstract available


    January 2021
  29. CARLSSON LMS, Jacobson P, Peltonen M
    Life Expectancy after Bariatric Surgery - the Swedish Obese Subjects Study. Reply.
    N Engl J Med. 2021;384:89.
    PubMed    


  30. GILLION V, Demoulin N, Devresse A
    Life Expectancy after Bariatric Surgery - the Swedish Obese Subjects Study.
    N Engl J Med. 2021;384:88.
    PubMed    


  31. TAGLIABUE E, Ceriani V, Pontiroli AE
    Life Expectancy after Bariatric Surgery - the Swedish Obese Subjects Study.
    N Engl J Med. 2021;384:88.
    PubMed    


    December 2020
  32. KUMANYIKA S, Dietz WH
    Solving Population-wide Obesity - Progress and Future Prospects.
    N Engl J Med. 2020;383:2197-2200.
    PubMed    


    November 2020
  33. LU KH, Broaddus RR
    Endometrial Cancer.
    N Engl J Med. 2020;383:2053-2064.
    PubMed    


    October 2020
  34. CARLSSON LMS, Sjoholm K, Jacobson P, Andersson-Assarsson JC, et al
    Life Expectancy after Bariatric Surgery in the Swedish Obese Subjects Study.
    N Engl J Med. 2020;383:1535-1543.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Obesity is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: